Sempre Health
PrivateLast Round
Series B
Extension
Sep 13, 2023
Total Funding Raised
$45.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sempre Health operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series B Extension round in September 2023.
Sempre Health is a digital health technology company that provides a behavior-based pricing platform to deliver dynamic copay discounts for prescription medications.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Pharma Supply Chain
Business Model
B2B2C
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sempre Health Comparables
Compare Sempre Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scripta Insights | 71% | |
| UnitedHealth Group | 70% | |
| McKesson | 70% |
For institutional investors. Book with your work email.
Sempre Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 13, 2023 | ||||
| Series B | Jun 15, 2021 | ||||
| Series A | Aug 29, 2018 | ||||
| Seed | Mar 28, 2017 | ||||
| Accelerator | May 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sempre Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifeforce Capital | Series B |
| Rethink Impact | Series B, Series A |
| Social Capital | Accelerator, Series A, Seed |
| Alchemist Accelerator | Seed, Accelerator |
| UPMC Enterprises | Series B Extension, Series B |
| Echo Health Ventures | Series B Extension |
| Cencora Ventures | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 489% MoM to 5.4K.
- Dec 30, 2025
Maintains HITRUST certification for security and compliance.
For institutional investors. Book with your work email.
Sempre Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sempre Health's valuation, stock price, and market status.
Is Sempre Health a public or private company?
Sempre Health is a private company.
What is the current stock price of Sempre Health?
Sempre Health is a private company, so its shares have no public market price. Caplight tracks Sempre Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sempre Health worth (valuation)?
Valuation information for Sempre Health is not publicly available.
Can I buy Sempre Health stock?
Sempre Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sempre Health's last funding round?
Sempre Health's most recent funding round was Series B Extension on September 13, 2023.
Who are the main investors in Sempre Health?
Key investors in Sempre Health include Rethink Impact, Social Capital, Echo Health Ventures, Cencora Ventures, Blue Venture Fund.
Will Sempre Health IPO soon?
No public IPO plans have been announced for Sempre Health.
How can I track Sempre Health secondary market activity?
Caplight tracks bids, offers, and trades in Sempre Health's shares on secondary markets.